Abstract CT219: Phase I trial of <i>in situ</i> vaccination with autologous <i>CCL21</i> gene-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced non-small cell lung cancer (NSCLC)

Bin Liu, Steven M. Dubinett, Robert D. Suh et al.|Cancer Research|2022

Cited by 1